RU2018125034A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018125034A3 RU2018125034A3 RU2018125034A RU2018125034A RU2018125034A3 RU 2018125034 A3 RU2018125034 A3 RU 2018125034A3 RU 2018125034 A RU2018125034 A RU 2018125034A RU 2018125034 A RU2018125034 A RU 2018125034A RU 2018125034 A3 RU2018125034 A3 RU 2018125034A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/966,759 US20160095908A1 (en) | 2005-06-14 | 2015-12-11 | Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies |
US14/966,759 | 2015-12-11 | ||
PCT/US2016/065898 WO2017100624A1 (en) | 2015-12-11 | 2016-12-09 | Botulinum toxin for primary disorders of mood and affect using neurotransmitter |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2018125034A RU2018125034A (ru) | 2020-01-13 |
RU2018125034A3 true RU2018125034A3 (ru) | 2020-04-15 |
Family
ID=59013649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018125034A RU2018125034A (ru) | 2015-12-11 | 2016-12-09 | Ботулотоксин для лечения первичных расстройств настроения и аффекта при участии нейромедиатора |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3386538A4 (ru) |
JP (1) | JP2019504824A (ru) |
KR (1) | KR20180093983A (ru) |
CN (1) | CN109069609A (ru) |
AU (1) | AU2016366428A1 (ru) |
BR (1) | BR112018011663A2 (ru) |
CA (1) | CA3007816A1 (ru) |
CO (1) | CO2018007096A2 (ru) |
IL (1) | IL259825A (ru) |
MX (1) | MX2018007105A (ru) |
RU (1) | RU2018125034A (ru) |
SG (1) | SG11201804840SA (ru) |
WO (1) | WO2017100624A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021137667A1 (ko) * | 2019-12-30 | 2021-07-08 | 주식회사 에이티지씨 | 보툴리눔 신경독소를 포함하는 파킨슨병 치료용 조성물 및 이를 이용한 파킨슨병 치료 방법 |
CN114384185A (zh) * | 2022-01-20 | 2022-04-22 | 北京航空航天大学 | 用于检测γ-氨基丁酸含量的试剂在制备诊断静脉流出障碍性疾病的试剂盒中的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8734810B2 (en) * | 2003-10-29 | 2014-05-27 | Allergan, Inc. | Botulinum toxin treatments of neurological and neuropsychiatric disorders |
US8609112B2 (en) * | 2003-10-29 | 2013-12-17 | Allergan, Inc. | Botulinum toxin treatments of depression |
US20070264373A1 (en) * | 2004-01-26 | 2007-11-15 | Ian Carroll | Toxin Induced Sympathectomy |
US20100266638A1 (en) * | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
US7655244B2 (en) * | 2005-02-01 | 2010-02-02 | Allergan, Inc. | Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
US8926991B2 (en) * | 2005-06-14 | 2015-01-06 | Botulinum Toxin Research Associates, Inc. | Botulinum toxin and the treatment of primary disorders of mood and affect |
US20070218084A1 (en) * | 2005-12-30 | 2007-09-20 | Fondazione Pierfranco E Luisa Mariani- Onlus | Method for the Mapping of the Epileptogenic Focus in the Pre-Surgical Evaluation of Patients with Intractable Epilepsy |
JP2010501566A (ja) * | 2006-08-21 | 2010-01-21 | プレクサ ファーマシューティカルズ, インコーポレイテッド | 中枢神経系障害の治療において使用するための多伝達物質トランスポータ阻害剤 |
WO2010013495A1 (ja) * | 2008-07-31 | 2010-02-04 | 財団法人化学及血清療法研究所 | 高度精製ボツリヌス毒素治療剤を有効成分として含有する薬学的組成物およびその利用 |
US9393291B2 (en) * | 2012-04-12 | 2016-07-19 | Botulinum Toxin Research Associates, Inc. | Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds |
US9480731B2 (en) * | 2013-12-12 | 2016-11-01 | Medy-Tox, Inc. | Long lasting effect of new botulinum toxin formulations |
-
2016
- 2016-12-09 CA CA3007816A patent/CA3007816A1/en not_active Abandoned
- 2016-12-09 AU AU2016366428A patent/AU2016366428A1/en not_active Abandoned
- 2016-12-09 MX MX2018007105A patent/MX2018007105A/es unknown
- 2016-12-09 CN CN201680079413.0A patent/CN109069609A/zh active Pending
- 2016-12-09 SG SG11201804840SA patent/SG11201804840SA/en unknown
- 2016-12-09 EP EP16873950.6A patent/EP3386538A4/en not_active Withdrawn
- 2016-12-09 BR BR112018011663A patent/BR112018011663A2/pt not_active IP Right Cessation
- 2016-12-09 JP JP2018529573A patent/JP2019504824A/ja active Pending
- 2016-12-09 WO PCT/US2016/065898 patent/WO2017100624A1/en active Application Filing
- 2016-12-09 RU RU2018125034A patent/RU2018125034A/ru not_active Application Discontinuation
- 2016-12-09 KR KR1020187019212A patent/KR20180093983A/ko unknown
-
2018
- 2018-06-05 IL IL259825A patent/IL259825A/en unknown
- 2018-07-06 CO CONC2018/0007096A patent/CO2018007096A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2019504824A (ja) | 2019-02-21 |
WO2017100624A1 (en) | 2017-06-15 |
KR20180093983A (ko) | 2018-08-22 |
IL259825A (en) | 2018-07-31 |
CA3007816A1 (en) | 2017-06-15 |
CO2018007096A2 (es) | 2018-11-22 |
RU2018125034A (ru) | 2020-01-13 |
CN109069609A (zh) | 2018-12-21 |
SG11201804840SA (en) | 2018-07-30 |
MX2018007105A (es) | 2018-09-07 |
BR112018011663A2 (pt) | 2018-12-04 |
AU2016366428A1 (en) | 2018-06-28 |
EP3386538A1 (en) | 2018-10-17 |
EP3386538A4 (en) | 2019-07-17 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20211203 |